Centene Upgraded to Outperform at Oppenheimer

Centene CNC is upgraded from Underperform to Outperform at Oppenheimer. The analysts raised their price target on Centene from $18 to $28.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst RatingsHealth CareManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!